Table 1.
EPA |
DHA |
Omega-3 Index |
||||
---|---|---|---|---|---|---|
Pre | Post | Pre | Post | Pre | Post | |
Placebo (n = 12) | 0.16 ± 0.01 | 0.25 ± 0.04 | 0.28 ± 0.07 | 0.32 ± 0.06 | 0.43 ± 0.08 | 0.54 ± 0.08 |
1 g/day (n = 6) | 0.19 ± 0.02 | 1.20 ± 0.13* | 0.17 ± 0.02 | 2.15 ± 0.22* | 0.36 ± 0.03 | 3.34 ± 0.26* |
2 g/day (n = 12) | 0.16 ± 0.01 | 1.71 ± 0.11* | 0.29 ± 0.08 | 2.01 ± 0.13* | 0.56 ± 0.13 | 3.72 ± 0.22* |
4 g/day (n = 22) | 0.20 ± 0.02 | 3.92 ± 0.21* | 0.21 ± 0.03 | 3.02 ± 0.17* | 0.41 ± 0.05 | 7.11 ± 0.27* |
Sham (n = 5) | 0.24 ± 0.03 | 4.41 ± 0.48* | 0.17 ± 0.02 | 3.421 ± 0.33* | 0.40 ± 0.05 | 7.49 ± 0.45* |
All values are means ± SE and are expressed as %total lipid content. Sham (i.e., no myocardial infarction) received 4 g/day; EPA = eicosapentaenoic acid; DHA = docasahexaenoic acid; omega-3 index = EPA + DHA.
P < 0.01, pre vs. post.